Fintech PR
USD 700 Billion Growth in Nutraceuticals Market Size 2023 – Industry Analysis, Market Trends, Market Growth, Opportunities | Sector Growing at 9.4% CAGR during the Forecast Period 2023 to 2030
NEW YORK, July 10, 2023 /PRNewswire/ — The global nutraceuticals market size was valued at USD 353 billion in 2022 and is expected to surpass USD 700 billion by 2030, registering a CAGR of 9.4% during the forecast period (2023- 2030), as highlighted in a report published by Facts and Factors.
Report Link with All Related Graphs & Charts: https://www.fnfresearch.com/nutraceuticals-market
Nutraceuticals Market: Overview
Nutraceuticals is a term used to describe a product that is derived from food sources and has additional health benefits in addition to providing food’s essential nutritional value. Food supplements, herbal products, and processed foods such as stews, cereals, and beverages are kept separate. These items are also used as medication and provide protection against chronic diseases.
According to the NCBI, nutraceuticals are used to improve health, slow the ageing process, prevent chronic diseases, and increase life expectancy. According to NIH researchers, nutraceuticals have attracted significant interest in the healthcare industry due to their therapeutic benefits. According to reports, nutraceuticals have been found to be effective against Alzheimer’s, cancer, allergies, diabetes, and Parkinson’s disease.
Get a Free Sample PDF of this Research Report for More Insights with Table of Content, Research Methodology, and Graphs – https://www.fnfresearch.com/sample/nutraceuticals-market
Our Free Sample Report Consists of the Following:
- 2023 Updated Report Introduction, Overview, and In-depth industry analysis
- 229+ Pages Research Report (Inclusion of Updated Research)
- Provide Chapter-wise guidance on Request
- 2023 Updated Regional Analysis with Graphical Representation of Size, Share & Trends
- Includes an Updated List of tables & figures
- Updated Report Includes Top Market Players with their Business Strategy, Sales Volume, and Revenue Analysis
- Facts and Factors Methodology
Key Industry Insights & Findings of the Nutraceuticals Market Reports:
- As per the analysis, the nutraceuticals market share is likely to grow above a CAGR of around 9.4% between 2023 and 2030.
- The nutraceuticals market size was worth around USD 353 billion in 2022 and is estimated to hit approximately USD 700 billion by 2030. Due to a variety of driving factors, the market is predicted to rise at a significant rate.
- The global nutraceuticals market is anticipated to record massive growth over the forecast period owing to the humungous consumption of functional foods has translated into a rise in the demand for nutraceuticals.
- Based on the product, the functional foods segment is predicted to contribute majorly towards the global market share over the forecast timeline.
- In terms of ingredients, the probiotics segment is projected to record the highest CAGR over 2023-2030.
- On the basis of application, the weight management & safety segment is slated to dominate the segmental surge over the forecast period.
- Region-wise, the Asia-Pacific Nutraceuticals market is projected to register the highest CAGR during the assessment period.
Industry Growth Drivers:
- Lifestyle-related disease awareness will drive worldwide market trends
Massive consumption of functional foods has resulted in an increase in demand for nutraceuticals, thereby accelerating the global expansion of the nutraceuticals market. The expansion of the global market will be driven by an increase in consumer concentration on health-promoting foods and awareness of lifestyle-related disorders.
In addition, a rise in consumer spending in developed nations and heightened health consciousness will expand the global market’s growth potential. Massive consumption of dietary supplements has shifted consumer preferences towards self-medication and treatment of lifestyle-related maladies, such as malnutrition. In turn, this has provided a solid foundation for global market expansion.
The expansion of the global nutraceuticals market has been greatly influenced by the ageing population, rising healthcare costs, and shifting dietary preferences. Global market demand has been positively impacted by technological advancements in the nutraceuticals industry and the use of artificial intelligence in the field.
Restraints:
- The global expansion of the nutraceutical industry will be hampered by the escalating cost of ingredients
The expansion of the global nutraceuticals industry will be stymied by the challenges encountered by industry participants during the manufacturing process and the lengthy extraction of ingredients required to produce nutraceuticals. In addition, rising costs of nutraceutical constituents can impede the global expansion of the industry.
Directly Purchase a Copy of The Report with TOC | Quick Delivery Available @ https://www.fnfresearch.com/buynow/su/nutraceuticals-market
Global Nutraceuticals Market: Segmentation
The global market for nutraceuticals is segmented by product, ingredient, application, and region.
The global nutraceuticals market is segmented by product into dietary supplements, functional beverages, and functional foods. In addition, it is anticipated that the functional foods segment, which accounted for over 40% of the global market share in 2022, will maintain its segmental dominance over the forecast period.
Ingredient-wise, the nutraceuticals industry across the globe is divided into probiotics, prebiotics, sweeteners, vitamins, whey proteins, proteins, omega-3, minerals, marine ingredients, lipids & fatty acids, krill, juices & concentrates, isoflavones, glucosamine, fruit & vegetables, flavours, fibres, fats & oils, fat replacers, essential oils, enzymes, dairy ingredients, colostrum, aloe vera, amino acids, carotenoids, carnitine and carbohydrates segments.
The global nutraceuticals market is segmented by application into weight management & safety, bone & joint health, energy & endurance, heart health, digestive health, animal nutrition, immune system, women’s health, and post-pregnancy & reproductive health.
Recent Developments:
- In the second quarter of 2022, The Kellogg Company, a U.S.-based food manufacturing firm, launched a new protein snack bar comprising 6 gms of protein and 90 calories. For the record, the snack bar is provided in two delectable flavors, rich chocolaty brownie sundae, and sweet berry vanilla. The move is predicted to boost the growth of the global nutraceuticals industry.
- In the first half of 2022, PepsiCo, Inc., a U.S.-based food company, introduced a hemp-infused drink in the U.S. Moreover, the energy drink branded as “Rockstar Unplugged”, comprises hemp seed oil, lemon balm, vitamin B, and spearmint. The strategic move will embellish the market growth trends in the U.S.
Have Any Query? Ask Our Experts: https://www.fnfresearch.com/inquiry/nutraceuticals-market
Competitive Players
The report contains qualitative and quantitative research on the global nutraceuticals market, as well as detailed insights and development strategies employed by the leading competitors. The report also provides an in-depth analysis of the market’s main competitors, as well as information on their competitiveness.
Some of the main players in the global nutraceuticals market include;
- DSM
- PepsiCo Inc.
- Amway
- Herbalife Nutrition Limited
- Pfizer Inc.
- Archer Daniels Midland Company
- Nestle S.A.
- The Kraft Heinz Company
- General Mills
- The Hain Celestial Group Inc.
- BASF SE
- Nature’s Bounty
- Abbot Industries
- General Mills Inc.
- Danone Corporation
- Glanbia Plc
- Tyson Foods
Key questions answered in this report:
- What is the growth rate forecast and market size for Nutraceuticals Market?
- What are the key driving factors propelling the Nutraceuticals Market forward?
- What are the most important companies in the Nutraceuticals Market Industry?
- What segments does the Nutraceuticals Market cover?
- How can I receive a free copy of the Nutraceuticals Market sample report and company profiles?
Report Scope:
Report Attribute |
Report Details |
Market Size in 2022 |
USD 353 Billion |
Market Forecast in 2030 |
USD 700 Billion |
Growth Rate |
CAGR of 9.4% |
Base Year |
2022 |
Forecast Years |
2023- 2030 |
Key Companies Covered |
DSM, PepsiCo Inc., Amway, Herbalife Nutrition Limited, Pfizer Inc., Archer Daniels Midland Company, Nestle S.A., The Kraft Heinz Company, General Mills, The Hain Celestial Group Inc., BASF SE, Nature’s Bounty, Abbot Industries, General Mills Inc., Danone Corporation, Glanbia Plc, Tyson Foods., and others. |
Segments Covered |
By Product, Ingredient, Application, and Region |
Regions Covered |
North America, Europe, Asia Pacific, Latin America, and the Middle East &, Africa |
Customization Scope |
Avail customized purchase options to meet your exact research needs. |
Request for Customization on this Report as per your requirements – https://www.fnfresearch.com/customization/nutraceuticals-market
(We tailor your report to meet your specific research requirements. Inquire with our sales team about customising your report.)
Regional Analysis:
- North American nutraceuticals market will lead globally
North America, which accounted for more than 30 percent of the global nutraceuticals market’s revenue in 2022, is anticipated to experience profitable expansion during the forecast period. The expansion of the regional market over 2023-2030 may be influenced by a rise in consumer health concerns and rising awareness of nutraceuticals.
The increase in the geriatric population and consumer expenditure on healthcare products, as well as changes in lifestyles, will contribute to the expansion of regional market trends. A rise in healthcare spending in the United States will drive the expansion of the regional market.
In addition, the Asia-Pacific region is anticipated to register the highest CAGR in the anticipated timeframe for the nutraceuticals industry. A rise in living standards, a rise in per capita income, and an increase in population are factors that are likely to influence the growth of the regional industry.
Global Nutraceuticals Market is segmented as follows:
By Product Segment Analysis
- Dietary Supplements
- Functional Beverages
- Functional Foods
By Ingredient Segment Analysis
- Probiotics
- Prebiotics
- Sweeteners
- Vitamins
- Whey Proteins
- Proteins
- Omega-3
- Minerals
- Marine Ingredients
- Lipids & Fatty Acids
- Krill
- Juices & Concentrates
- Isoflavones
- Glucosamine
- Fruit & Vegetables
- Flavors
- Fibers
- Fats & Oils
- Fat Replacers
- Essential Oils
- Enzymes
- Dairy Ingredients
- Colostrum
- Aloe Vera
- Amino Acids
- Carotenoids
- Carnitine
- Carbohydrates
By Application Segment Analysis
- Weight Management & Safety
- Bone & Joint Health
- Energy & Endurance
- Heart Health
- Digestive Health
- Animal Nutrition
- Immune System
- Women’s Health
- Post-Pregnancy & Reproductive Health
By Region
- North America
- The U.S.
- Canada
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Southeast Asia
- Rest of Southeast Asia
- The Middle East & Africa
- GCC
- South Africa
- Rest of the Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
Browse Other Related Research Reports from Facts & Factors
- Chatbot Market: https://www.fnfresearch.com/chatbot-market
- Holographic Display Market: https://www.fnfresearch.com/holographic-display-market
- Online Education Market: https://www.fnfresearch.com/online-education-market
- Plant-based Milk Market: https://www.fnfresearch.com/plant-based-milk-market
- Supervisory Control and Data Acquisition (SCADA) Systems Market: https://www.fnfresearch.com/scada-systems-market
Browse Through Facts and Factors Coverage of the Global Food & Beverages Industry
Follow Us on – LinkedIn | Twitter | Facebook
About Us:
Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds.
Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.
Contact Us:
Facts and Factors
Tel: +1 347 690-0211
USA/Canada Toll-Free No. +44 2032 894158
Email: [email protected]
Web: https://www.fnfresearch.com
Logo – https://mma.prnewswire.com/media/1981423/FnF_Research_Logo.jpg
Fintech PR
Bybit Champions Web3 Innovation and Strengthens Ties with Asia’s Crypto Community at Taipei Blockchain Week
DUBAI, UAE, Dec. 24, 2024 /PRNewswire/ — Bybit, the world’s second-largest cryptocurrency exchange, debuted at the Taipei Blockchain Week Dec. 12 to 14, 2024, spotlighting the vibrant Web3 innovations on its platform alongside a dynamic roster of its strategic Layer 1 ecosystem partners.
Featuring side events in collaboration with the Solana Foundation, the Sui Foundation, and a dazzling lineup of multichain projects, Bybit Web3 dedicated the Taipei tour to building up communities and deepening connections with Web3 ecosystem partners. The Bybit delegation also took the stage to uncover the latest insights on Web3, building with a purpose, and the future of blockchain utilities and DeFi.
Purpose, Innovation, and Partnerships
Representing Bybit at the conference were MK Chin, Core Contributor for Blockchain for Good Alliance and Head of Marketing of Bybit Web3, and Angela Huang, Bybit VIP Relationship Manager, at various panels.
Expanding on blockchain technology’s potential in building better realities for all, Chin joined as a panellist in the session Marketing Web3: Strategies to Engage and Onboard the Next Billion Users. Chin shared learnings and actionable insights from the Bybit-supported Blockchain for Good initiative (BGA), elaborating on both real-world utilities of blockchain technologies and the trickling down of benefits to grassroot communities.
Meanwhile, Angela Huang moderated three sessions closely tied to Bybit’s mission, steering conversations on crucial industry topics:
- The panel Bridging TradFi and DeFi: The Exchange’s Role in User Onboarding on Dec. 12 examined how exchanges could elevate access to the digital economy for users at scale.
- On Dec. 13, Networked Intelligence: The Rise of Decentralized AI explored the intersection of blockchain and AI, showcasing their potential to transform and democratize finance.
- The Building for Impact: How Female Founders Drive Purpose-Driven Innovation panel on Dec. 14 highlighted the evolving role of women leaders in driving solution-oriented innovation.
Another highlight at the event was amplified globally via Bybit Livestream. Collaborating with the Sui Foundation, Ondo, DeepBook, Scallop, NAVI, and other leading projects, Bybit Web3 led a critical debate on the future of Sui’s growth strategy: Sui Ecosystem Showdown: Mass Adoption vs. Native Growth. Hosted by Emily Bao, Head of Web3 and Spot at Bybit, the livestream attracted over 6,500 viewers live at the Taipei Blockchain Week and globally on Dec. 13.
Deepening Bonds: Key Web3 Ecosystems and Communities
Bybit Web3 brought the local community closer to its world-class ecosystem partners with engaging community events, co-hosting Taiwan DeFi Flow with Sui and Scallop on Dec. 12, and Solana Ecosystem Taipei Greetings with the Solana Foundation and Solar with the support of Orderly Network, Zetachain, Jupiter, and Sonic, on Dec. 14. Through collaborations and innovation, Bybit Web3 opens up new on-chain possibilities for partners and stakeholders to expand the Web3 universe.
These relaxed evening gatherings provided a convivial backdrop for like-minded builders and entrepreneurs to network, exchange ideas, and celebrate their shared enthusiasm for DeFi and dApps in Asia’s growing Web3 innovation hub.
“It’s been an incredible experience connecting with the builders, believers, users, creators, and supporters driving innovation on Solana and Sui. These moments remind us of the heart and spirit of Web3—a vibrant ecosystem shaped by collaboration and shared vision. I’m deeply proud to witness this growth, grateful for every connection made, and excited for the road ahead,” said MK Chin, Core Contributor for Blockchain for Good Alliance and Head of Marketing of Bybit Web3.
“Taipei Blockchain Week showcased the immense growth and potential of Web3 innovation in Asia. Representing Bybit, I had the honor to collaborate with industry leaders to explore Web3’s limitless possibilities, from DeFi and AI to real-world applications. Together, we are shaping a more inclusive global crypto community,” said Angela Huang, Bybit VIP Relationship Manager.
In the past year, Bybit has seen exponential growth in its user base, surging to over 60 million by the end of 2024. It has also invested in vertical growth through community engagements across the world. Connected by the passion for the future of crypto, blockchain, and Web3, the Bybit family is on track to building an inclusive and sustainable path to growth for the industry.
#Bybit / #TheCryptoArk / #BybitWeb3
About Bybit Web3
Bybit Web3 is redefining openness in the decentralized world, creating a simpler, open, and equal ecosystem for everyone. We are committed to welcoming builders, creators, and partners in the blockchain space, extending an invitation to both crypto enthusiasts and the curious, with a community of over 130 million wallet addresses across over 30 major ecosystem partners, and counting.
Bybit Web3 provides a comprehensive suite of Web3 products designed to make accessing, swapping, collecting and growing Web3 assets as open and simple as possible. Our wallets, marketplaces and platforms are all backed by the security and expertise that define Bybit as the world’s second-largest cryptocurrency exchange by trading volume, trusted by over 50 million users globally.
Join the revolution now and open the door to your Web3 future with Bybit.
For more details about Bybit Web3, please visit Bybit Web3.
About Bybit
Bybit is the world’s second-largest cryptocurrency exchange by trading volume, serving a global community of over 60 million users. Founded in 2018, Bybit is redefining openness in the decentralized world by creating a simpler, open and equal ecosystem for everyone. With a strong focus on Web3, Bybit partners strategically with leading blockchain protocols to provide robust infrastructure and drive on-chain innovation. Renowned for its secure custody, diverse marketplaces, intuitive user experience, and advanced blockchain tools, Bybit bridges the gap between TradFi and DeFi, empowering builders, creators, and enthusiasts to unlock the full potential of Web3. Discover the future of decentralized finance at Bybit.com.
For more details about Bybit, please visit Bybit Press
For media inquiries, please contact: [email protected]
For updates, please follow: Bybit’s Communities and Social Media
Discord | Facebook | Instagram | LinkedIn | Reddit | Telegram | TikTok | X | Youtube
Photo – https://mma.prnewswire.com/media/2587313/1.jpg
Photo – https://mma.prnewswire.com/media/2587314/2.jpg
Logo – https://mma.prnewswire.com/media/2267288/Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/bybit-champions-web3-innovation-and-strengthens-ties-with-asias-crypto-community-at-taipei-blockchain-week-302338874.html
Fintech PR
AIMA Technology Welcomes Top U.S. Dealers to Shape the Future Together
TIANJIN, China, Dec. 24, 2024 /PRNewswire/ — On December 7, 2024, AIMA Technology Group warmly invited a delegation of five top-performing U.S. IBD dealers to visit its headquarters. Accompanying the group was Angela Zheng, CEO of AIMA’s U.S. subsidiary, AIMA EBIKE, along with her sales, marketing, and customer service teams. This visit not only marked a deepened connection between AIMA and the mainstream U.S. market but also provided U.S. dealers with a valuable opportunity to witness AIMA Technology’s globally leading capabilities in research, development, and manufacturing of electric mobility solutions.
The delegation first toured AIMA’s state-of-the-art factory in Tianjin. Aima Technology possesses production factories with extremely high levels of intelligent manufacturing Additionally, AIMA has integrated advanced technologies such as AI visual recognition and established a CNAS-certified R&D laboratory, maintaining its industry leadership in intelligent transformation. During the tour, the dealers were deeply impressed by AIMA’s cutting-edge technology, large-scale production capabilities, and relentless pursuit of excellence in product development and manufacturing. They expressed that this rare visit not only enhanced their understanding of AIMA but also strengthened their confidence in promoting AIMA products as a symbol of outstanding performance and exceptional quality to their customers.
Furthermore, AIMA Technology’s R&D team engaged in in-depth discussions with the dealers regarding the new models AIMA EBIKE plans to launch in 2025. The dealers test-rode prototypes of the latest models and shared their innovative insights. They expressed high praise for AIMA’s product innovation capabilities and market acumen, recognizing these as key factors that distinguish AIMA in the industry.
Later, the dealers joined AIMA Technology’s team to witness the rollout of the 10,000th AIMA E-Bike. This milestone moment showcased AIMA’s exceptional manufacturing strength and market influence. The dealers were inspired and expressed strong confidence in the promising future of their partnership with AIMA.
This visit from the top-tier U.S. dealer delegation not only deepened mutual trust and friendship but also injected new momentum into AIMA’s ambition to become a leader in the U.S. E-Bike industry by focusing on the IBD channel. Looking ahead, AIMA Technology will continue to strive to provide market-leading performance and quality, enhancing its product development and manufacturing capabilities while working hand-in-hand with global dealers to create an even brighter future.
Photo – https://mma.prnewswire.com/media/2586564/1.jpg
Photo – https://mma.prnewswire.com/media/2586566/2.jpg
Logo – https://mma.prnewswire.com/media/2449955/AIMA_Technology_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/aima-technology-welcomes-top-us-dealers-to-shape-the-future-together-302338745.html
Fintech PR
FXGiants Online Trading Platform Launches Bonus Initiative to Reward Traders
HAMILTON, Bermuda, Dec. 19, 2024 /PRNewswire/ — FXGiants has recently launched a series of exciting bonuses. Participants on the FXGiants‘ online trading platform can now amplify their trading potential with a broad spectrum of bonuses that are tailored to fit different trading needs. These bonuses not only add extra value but also act as a safety net for traders to explore the financial markets without risking too much.
“Our goal with these deposit bonus options is to empower traders of all levels,” said Christopher Oates, the spokesperson for FXGiants. “Under this scheme, we have diverse categories, including Bonus Maximiser, Booster Bonus, and the Bonus Advantage. These bonuses are designed to provide flexibility to clients as they trade on the FXGiants online trading platform.”
Exploring the FXGiants Bonus Options
The bonus options at FXGiants come with versatile advantages. The Bonus Maximiser provides a full 100% boost on all deposits without limit, whereas the Booster Bonus offers a 40% bonus on all deposits up to $4,000 for traders who want to moderately enhance their capital. On the other hand, the Bonus Advantage provides a 60% bonus on deposits up to $5,000, giving traders a better handle on risk. These bonuses enhance the trading experience on the FXGiants online trading platform.
“At FXGiants, we are committed to a trading environment that meets the evolving needs of our clients,” Oates added. “Our online trading platform is a robust ecosystem designed to support traders with advanced execution, extensive market insights, and continuous improvements. As we move forward, we will keep expanding our offerings to ensure that traders have access to the best resources and support.”
About FXGiants
FXGiants stands out as an international broker providing access to over 300 financial instruments across 6 asset classes. Traders can operate through the popular MetaTrader 4 platform, and benefit from exceptional trading conditions such as competitive spreads, flexible leverage, and fast execution. With deposit boosters, partnership programs, an educational blog, and account types tailored to both novice and experienced traders, FXGiants remains dedicated to delivering a one-stop trading solution.
Terms & Conditions apply. Bonus cannot be withdrawn.
All trading involves risk. It is possible to lose all your capital.
FXGiants is a trade name of Notesco Int Limited; a company incorporated in Anguilla with registration number A000001800 and registered address The Valley, AI2640, Cosely Drive, 1338, AI.
Website: https://www.fxgiants.com/
View original content:https://www.prnewswire.co.uk/news-releases/fxgiants-online-trading-platform-launches-bonus-initiative-to-reward-traders-302338463.html
-
Fintech7 days ago
Fintech Pulse: Your Daily Industry Brief (Revolut, Bestow, Advyzon, Tyme Group, Nubank)
-
Fintech5 days ago
Fintech Pulse: Your Daily Industry Brief (Chime, ZBD, MiCA)
-
Fintech PR4 days ago
According to Tickmill survey, 3 in 10 Britons in economic difficulty: Purchasing power down 41% since 2004
-
Fintech5 days ago
Airtm Enhances Its Board of Directors with Two Strategic Appointments
-
Fintech5 days ago
SPAYZ.io prepares for iFX EXPO Dubai 2025
-
Fintech PR4 days ago
President Emmerson Mnangagwa met this week with Zambia’s former Vice President and Special Envoy Enoch Kavindele to discuss SADC’s candidate for the AfDB
-
Fintech PR4 days ago
Stay Cyber Safe This Holiday Season: Heimdal’s Checklist for Business Security
-
Fintech PR6 days ago
Gan & Lee Pharmaceuticals Announces U.S. FDA Clearance of the IND application for the innovative Bi-weekly GLP-1RA GZR18 Injection, Bofanglutide, with chronic weight management Indication (A Phase 2 head-to-head with Tirzepatide clinical trial)